401 related articles for article (PubMed ID: 28831030)
1. FDA's new plan to reduce the nicotine in cigarettes to sub-addictive levels could be a game-changer.
Proctor RN
Tob Control; 2016 Sep; 26(5):487-488. PubMed ID: 28831030
[No Abstract] [Full Text] [Related]
2. Believability of Cigarette Warnings About Addiction: National Experiments of Adolescents and Adults.
Lazard AJ; Kowitt SD; Huang LL; Noar SM; Jarman KL; Goldstein AO
Nicotine Tob Res; 2018 Jun; 20(7):867-875. PubMed ID: 29059352
[TBL] [Abstract][Full Text] [Related]
3. Will the FDA's New Tobacco Strategy Be a Game Changer?
Rubin R
JAMA; 2017 Dec; 318(24):2413-2415. PubMed ID: 29214315
[No Abstract] [Full Text] [Related]
4. Electronic cigarettes.
Blaha MJ; Ratchford EV
Vasc Med; 2019 Jun; 24(3):267-269. PubMed ID: 30931840
[No Abstract] [Full Text] [Related]
5. Position statement on electronic cigarettes or electronic nicotine delivery systems.
Bam TS; Bellew W; Berezhnova I; Jackson-Morris A; Jones A; Latif E; Molinari MA; Quan G; Singh RJ; Wisotzky M;
Int J Tuberc Lung Dis; 2014 Jan; 18(1):5-7. PubMed ID: 24365545
[No Abstract] [Full Text] [Related]
6. Novel nicotine delivery systems and public health: the rise of the "e-cigarette".
Cobb NK; Byron MJ; Abrams DB; Shields PG
Am J Public Health; 2010 Dec; 100(12):2340-2. PubMed ID: 21068414
[No Abstract] [Full Text] [Related]
7. Reengineering Addiction - The Tobacco Industry's Potential Response to a Nicotine Standard for Cigarettes.
El-Hellani A; Wagener TL; Brinkman MC
N Engl J Med; 2024 May; 390(18):1639-1641. PubMed ID: 38708820
[No Abstract] [Full Text] [Related]
8. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
Jenson D; Lester J; Berman ML
Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
[TBL] [Abstract][Full Text] [Related]
9. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
Walele T; Sharma G; Savioz R; Martin C; Williams J
Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788
[TBL] [Abstract][Full Text] [Related]
10. Flavoured tobacco products in the USA: synthesis of recent multidiscipline studies with implications for advancing tobacco regulatory science.
Stanton CA; Villanti AC; Watson C; Delnevo CD
Tob Control; 2016 Nov; 25(Suppl 2):ii1-ii3. PubMed ID: 27856996
[No Abstract] [Full Text] [Related]
11. The U.S. Food and Drug Administration's New Plan to Combat Tobacco's Staggering Public Health Toll.
Abram A; Zeller M
Ann Am Thorac Soc; 2019 Jan; 16(1):40-43. PubMed ID: 30339472
[No Abstract] [Full Text] [Related]
12. No sisyphean task: how the FDA can regulate electronic cigarettes.
Paradise J
Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
[TBL] [Abstract][Full Text] [Related]
13. E-cigarettes-new product, old tricks.
The Lancet Oncology
Lancet Oncol; 2018 Dec; 19(12):1543. PubMed ID: 30507412
[No Abstract] [Full Text] [Related]
14. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence.
Foulds J
Int J Clin Pract; 2010 Feb; 64(3):292-4. PubMed ID: 20456168
[No Abstract] [Full Text] [Related]
15. FDA's regulatory shift on tobacco control.
Yang YT
Prev Med; 2018 Aug; 113():153-155. PubMed ID: 29866276
[TBL] [Abstract][Full Text] [Related]
16. The emerging phenomenon of electronic cigarettes.
Caponnetto P; Campagna D; Papale G; Russo C; Polosa R
Expert Rev Respir Med; 2012 Feb; 6(1):63-74. PubMed ID: 22283580
[TBL] [Abstract][Full Text] [Related]
17. A Nicotine-Focused Framework for Public Health.
Gottlieb S; Zeller M
N Engl J Med; 2017 Sep; 377(12):1111-1114. PubMed ID: 28813211
[No Abstract] [Full Text] [Related]
18. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE
J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055
[TBL] [Abstract][Full Text] [Related]
19. Emerging nicotine delivery products. Implications for public health.
Benowitz NL
Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
[TBL] [Abstract][Full Text] [Related]
20. Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.
Benowitz NL; Henningfield JE
Prev Med; 2018 Dec; 117():5-7. PubMed ID: 29944901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
